Prospect News: News for Recipharm AB

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Price: $0.00

Account balance: $0.00

Add to balance / Manage account

User: lxbfYeaa

Log out

Prospect News home > Main news index > All issuers starting with R > Issuers starting with R, BK only > All stories on Recipharm AB > Stories on Recipharm AB, BK only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Recipharm AB

2/5/2025	BK	Moody's rates Recipharm loan B3
4/19/2023	BK	S&P trims Recipharm
4/4/2023	BK	Moody's downgrades Recipharm
9/22/2022	BK	Fitch alters Recipharm outlook to stable
3/21/2022	BK	S&P revises Recipharm view to stable
3/18/2021	BKIG	S&P rates Recipharm, loan B
3/17/2021	BK	Moody's assigns Recipharm B2
3/17/2021	BK	Fitch gives Recipharm B, loan B+

©2026 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.